Andrew D.C. LaFrence - 20 May 2021 Form 4 Insider Report for Vyant Bio, Inc. (VYNT)

Role
Chief Financial Officer
Signature
/s/ Andrew LaFrence
Issuer symbol
VYNT
Transactions as of
20 May 2021
Transactions value $
$9,837
Form type
4
Filing time
21 May 2021, 16:05:24 UTC
Previous filing
13 Jul 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $9.84K +3K +10.23% $3.28* 32.3K 20 May 2021 Direct
holding VYNT Common Stock, $0.0001 par value 26.9K 20 May 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.